Advanced Leukemia Successfully Treated With First Use Of Antibody And Stem Cell Transplantation
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.
Read the original:
Advanced Leukemia Successfully Treated With First Use Of Antibody And Stem Cell Transplantation
Related posts:
- Autologous Stem Cell Transplantation For Soft Tissue Sarcoma: Insufficient Research Into Therapy Due to a lack of suitable studies, it is unclear whether patients with soft tissue sarcoma can benefit from autologous haematopoietic stem cell transplantation. With this type of therapy, some...
- Advanced Cell Technology Files IND With FDA For First Human Clinical Trial Using Embryonic Stem Cells To Treat Eye Disease Advanced Cell Technology, Inc. (OTCBB:ACTC) announced that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study...
- LFB’s Recombinant Anti-CD20 Monoclonal Antibody Is Granted Orphan Drug Status In Europe For Chronic Lymphocytic Leukemia The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLL). This approval from the EMEA's Committee for Orphan Medicinal...
- Celldex Therapeutics Presents Positive Results From Phase 2 Study Of The Antibody-Drug Conjugate Product Candidate CDX-011 In Advanced Breast Cancer Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced the results of a positive Phase 2 study of CDX-011 (formerly CR011-vcMMAE), in patients with heavily pre-treated, locally advanced or metastatic breast cancers. As...
- Cholesterol-Lowering Drugs Also May Protect Stem Cell Transplant Patients From A Potentially Deadly Complication Cholesterol-lowering drugs known as statins are among the most prescribed medicines in the U.S. Now a new study by researchers at Fred Hutchinson Cancer Research Center indicates that statins may...
- Transplantation Of Stem Cells Alleviates Side Effects Of Radiotherapy In Rats Human embryonic stem cells could help people with learning and memory deficits after radiation treatment for brain tumors, suggests a new UC Irvine study. Research with rats found that transplanted...
- Islet Cell Transplantation In Scotland The Scottish National Blood Transfusion Service has opened a new laboratory in Edinburgh to offer around 12 people a year islet cell transplant therapy. Islet cell transplant therapy is a...
- New Ethical Questions Are Being Raised In Stem Cell Research A groundbreaking discovery two years ago that turned ordinary skin cells back into an embryonic or "pluripotent" state was hailed as the solution to the controversial ethical question that has...
- Arno Therapeutics Announces Poster Presentation At ASH Annual Meeting Demonstrating Anti-Leukemic Stem Cell Activity Of AR-42 Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the presentation of a poster at the annual American Society of Hematology (ASH) meeting that describes the...
- New Stem Cell Technology Developed At Hebrew University – Leads To Better Treatment For Complicated Bone Fractures A novel technology involving use of stem cells, developed by Hebrew University of Jerusalem researchers, has been applied to provide better and rapid healing for patients suffering from complicated bone...
- Univ. Of Nebraska Board Of Regents Votes To Maintain Current Embryonic Stem Cell Policy The University of Nebraska Board of Regents last week voted 4-4 not to restrict embryonic stem cell research policy beyond current federal and state limits, the New York Times reports....
- $11 Million NIH Grant For Stem Cell Research Awarded To Rhode Island Hospital Rhode Island Hospital has received an $11 million grant to fund research that will lead to a general understanding of stem cell biology and identify unique approaches to tissue regeneration...
- StemCells, Inc. Welcomes Approval Of First Embryonic Stem Cell Lines Under New NIH Guidelines StemCells, Inc. (NASDAQ: STEM) announced that it welcomes the approval yesterday by the National Institutes of Health (NIH) of the first 13 human embryonic stem cell (hESC) lines for use...
- Hebrew University, American Researchers Show Genetic ‘trigger’ To Stem Cell Differentiation A gene which is essential for stem cells' capabilities to become any cell type has been identified by researchers at the Hebrew University of Jerusalem and the University of California,...
- Adult Stem Cells Safe, Promising In Treating Heart Attack Patients An FDA-approved clinical trial is the first to show that treating patients with adult stem cells after a heart attack is safe and that it appears to repair damaged heart...
2009 November 7 by Admin
« Lundbeck Starts Clinical Phase IIa With Lu AA24493 (cEPO) In Friedreich’s Ataxia In A Study Also Assessing Efficacy Via Biomarkers
University Of Central Florida Med Students Volunteer To Help Sick Kids, Families In Community On Saturday »
No comments yet